Rhythm Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.

CEO

David P. Meeker

CEODavid P. Meeker

Employees

283

Employees283

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2008

Founded2008

Employees

283

Employees283

RYTM Key Statistics

Market cap

4.33B

Market cap4.33B

Price-Earnings ratio

-24.19

Price-Earnings ratio-24.19

Dividend yield

—

Dividend yield—

Average volume

550.86K

Average volume550.86K

High today

$68.26

High today$68.26

Low today

$66.24

Low today$66.24

Open price

$66.24

Open price$66.24

Volume

703.26K

Volume703.26K

52 Week high

$68.58

52 Week high$68.58

52 Week low

$38.85

52 Week low$38.85

Analyst ratings

100%

of 12 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own RYTM. This list is generated using Robinhood data, and it’s not a recommendation.